NTLA Dividend History & Analysis | N/A Yield
NTLA has a dividend yield of N/A and paid N/A per share in the last 12M. Complete payout history, full analyses and peer comparison.
Top Dividend Payers in Biotechnology
| SYMBOL | MARKET CAP USD | YIELD TTM | YIELD ON COST 5y |
|---|---|---|---|
| ABBV | 369,388 M | 3.34% | 9.56% |
| QIA | 8,383 M | 5.35% | 5.37% |
| NOV | 159,380 M | 4.64% | 6.00% |
| AMGN | 187,563 M | 3.07% | 5.65% |
| GILD | 173,409 M | 2.65% | 5.79% |
| SYMBOL | MARKET CAP USD | GROWTH RATE | CONSISTENCY |
|---|---|---|---|
| HLN | 44,640 M | 30.09% | 100.0% |
| NOV | 159,380 M | 25.64% | 91.9% |
| BIM | 12,725 M | 9.76% | 96.0% |
| AMGN | 187,563 M | 7.84% | 100.0% |
| ABBV | 369,388 M | 5.98% | 100.0% |
NTLA Dividend FAQ
Intellia Therapeutics (NASDAQ: NTLA) is a clinical-stage gene-editing firm headquartered in Cambridge, MA, that pursues curative genome-editing medicines. Its lead in-vivo pipeline includes NTLA-2001, now in a Phase 2 trial for transthyretin amyloidosis, where interim data showed an average ≈ 80 % reduction in serum TTR levels, and NTLA-2002, advancing through Phase 1/2 for hereditary angioedema. The company also develops proprietary engineered-cell programs targeting multiple cancers and autoimmune disorders, leveraging collaborations with AvenCell, Kyverna, ONK Therapeutics and ReCode.
What is the Dividend Yield of NTLA?
As of April 2026, NTLA's dividend yield is %. This is calculated by dividing the trailing 12-month dividend rate (TTM rate) of - by the current share price of 13.13.
Does NTLA pay a dividend?
As of April 2026 NTLA does not pay a dividend.
How often does NTLA pay dividends?
Over the last 12 months, NTLA has issued dividend payments.
NTLA dividend forecast
Based on historical data, the forecasted dividends per share for NTLA for the next payments are between 0 (+0.0%) and 0 (+0.0%). This suggests the dividend will remain relatively stable. The expected Yield for the next 12 months is about -%.
Will NTLA pay dividends in 2026?
The next Ex-Dividend date for Intellia Therapeutics (NTLA) is currently unknown.
What is the next Ex-Dividend Date for NTLA?
The next Ex-Dividend date for Intellia Therapeutics (NTLA) is currently unknown. We automatically update the next Ex-Dividend date when it is announced.
What is the Dividend Growth of NTLA?
NTLA's average dividend growth rate over the past 5 years is -% per year.
What is the Yield on Cost of NTLA?
NTLA's 5-Year Yield on Cost is -%. If you bought NTLA's shares at 80.23 five years ago, your current annual dividend income (- per share, trailing 12 months) equals -% of your original purchase price.
What is the Payout Consistency of NTLA?
NTLA Payout Consistency is 0.0%. The payout consistency is a proprietary measure of how consistently a company has paid dividends over its lifetime and blends growth rate, number of dividend payments, interruptions or lowering dividends into one number.
Does NTLA have a good Dividend Yield?
NTLA's % Dividend Yield is considered as unknown.
What is the Dividend Payout Ratio of NTLA?
The Dividend Payout Ratio of NTLA is unknown.
What is the Dividend Rating of NTLA?
NTLA's Overall Dividend Rating is (unknown). Ratings surpassing 65% are regarded as acceptable, exceeding 75% are favorable and surpassing 85% are strong.
Key Metric Definitions
Annual dividend per share divided by current share price.
Percentage of earnings paid as dividends. Below 60% = safe, above 100% = unsustainable.
Percentage of Free Cash Flow paid as dividends. More reliable than Payout Ratio since it measures actual cash.
Compound annual growth rate of dividends over the last 5 years.
Reliability of dividend payments over lifetime. Penalizes cuts and pauses.
Your effective yield if you bought 5 years ago. Shows dividend growth impact over time.
Consecutive years of dividend payments. 25+ years = Dividend Aristocrat.
Proprietary score (0-100) combining yield, growth, safety and consistency.
Last update: 2026-03-31 02:37 UTC